The vibrant life science cluster of the San Francisco Bay Area is continuously growing – learn about many of the people and companies within the region with our spotlights below. Also, for more San Francisco biotech news, be sure to subscribe to the daily newsletter.
With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]
LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]
USING AI TO ACCELERATE THE PROMISE OF PRECISION MEDICINE By Marie Daghlian Can the application of artificial intelligence (AI) and machine learning (ML) accelerate precision medicine and deliver on its promise? The answer is an unequivocal “yes,” but we are not there yet. There are opportunities along the entire health care value chain but there […]
BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports, special features and more. Today’s feature is a Q&A with Sara Radcliffe, President & CEO, California Life Sciences […]
By Marie Daghlian Attendees at the BIO Investor Forum braved the cacophony of striking hotel workers’ shouts and drumbeats to meet with each other, tell their stories, seek investment and partnering opportunities, and gain insight into ongoing trends in the sector over two days in mid October in sunny San Francisco. According to the Biotechnology […]
EPPICon’s 18th Annual Meeting is just around the corner featuring sessions on digital health, data driven drug discovery, and personalized genomics using bioinformatics. EPPIC Global’s mission is to advance healthcare by providing entrepreneurship, mentoring and networking opportunities. Since 1998, EPPIC Global has promoted interactions at the intersection of tech and healthcare to surface innovative ideas […]
Charles River is excited to announce its 3rd Annual Viral Clearance and Viral Safety Summit on October 9-10, 2018 in San Francisco, CA. We have lined up speakers from the Paul Ehrlich Institute, Lysogene, Amgen, Boehringer Ingelheim and CSL Behring among other companies to bring you a comprehensive look at current industry and regulatory practices […]
Since 2014, Big3Bio has shared the rise-and-fall coverage of Elizabeth Holmes and Theranos. With the most recent development of Holmes being indicted, we’ll keep this post updated throughout the rest of 2018. UPDATED COVERAGE 9/5/18 Theranos to Dissolve – The Wall Street Journal 8/23/18 Bad Blood Author Carreyrou On Elizabeth Holmes And Theranos – CNBC […]
Urdea Talks About Why Diagnostics Companies Fail By Marie Daghlian The classroom at QB3 on the UCSF campus was small, only sixty seats, but it was packed—all the seats were taken and at least thirty more people lined the walls and sat in the center aisle. Before introducing Mickey Urdea, health sciences incubator QB3 Executive […]
By Marie Daghlian The San Francisco Bay Area continues to be a hotbed of company formation and financing not only in tech but also in biotech. Biotech and health-related companies raked in $1.2 billion in venture capital financing in the Q1 2018 in 32 deals. While it was less than the $1.7 billion raised in […]
With so many patients relying on novel therapeutics for neurological disorders, the stakes are high when therapies reach the clinic. The best way to improve your chance for success is to design rigorous preclinical studies that include reproducible endpoints and robust biomarkers that predict clinical efficacy. Charles River hopes you join us as we further […]
Startup Inflammatix, founded in 2016 in Burlingame, California, takes a different approach to diagnosing infections. Rather than seeking the pathogen causing the infection, it uses a data-driven approach to evaluate the body’s immune system response to provide a diagnosis in as little as an hour. Big3Bio editor Marie Daghlian spoke with Dr. Timothy Sweeney, co-founder […]
By Marie Daghlian The buzz around artificial intelligence, or AI, is palpable—similar to the buzz around CRISPR and immuno-oncology just a few years ago. VCs are throwing money at startups that are using AI. Proponents say it can solve the world’s problems, do what humans cannot. Others worry that it will run away from humans, […]
By Marie Daghlian Editor, Big3Bio The life sciences industry is doing great. That was the considered opinion of life sciences industry experts that was also exemplified by the buoyant mood of many of the 30,000 or so people involved in its business who descended on San Francisco during the second week of January to attend […]
Charles River’s 2nd Annual Viral Safety and Viral Clearance Summit will be held October 10 – 11, 2017 at the San Mateo Marriott in San Mateo, CA. The 2-day summit, located in the Bay Area, unites industry professionals in an interactive setting to share updates and discuss trends in the realm of viral safety and […]